ADALVO LIMITED
Adalvo Secures First EU Generic Approval for Liraglutide Pre-Filled Pen
June 13, 2024 06:38 ET | ADALVO LIMITED
Adalvo announces the successful DCP approval for Liraglutide pre-filled pen, marking it as the first generic approval in the EU.
cmi_logo.png
[Latest] Global Protein Purification and Isolation Market Size/Share Worth USD 22,003.8 Million by 2033 at a 9.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
June 10, 2024 09:00 ET | Custom Market Insights
Austin, TX, USA, June 10, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Protein Purification and Isolation Market Size, Trends and Insights By Product...
SERMONIX NEW LOGO JPEG (2).jpg
Sermonix Pharmaceuticals Announces Chinese Approval of Investigational New Drug Application for Lasofoxifene
June 06, 2024 09:00 ET | Sermonix Pharmaceuticals Inc.
IND approval in China allows Shanghai Henlius Biotech, Sermonix’s Chinese development partner for oral lasofoxifene, to enroll ELAINE-3 trial patients in ChinaUnder strategic collaboration agreement...
23andMe_Logo_grey.png
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
June 03, 2024 08:00 ET | 23andMe, Inc.
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate acceptable safety and...
Biognosys Newton, Massachusetts proteomics facility
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
May 30, 2024 09:15 ET | Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics
Rhino Health and Medinexo Partner to Expand Data Diversity in Therapeutic Development
May 22, 2024 15:35 ET | Rhino Health
Rhino Health and Medinexo are partnering to provide federated access to a global network of hospitals to accelerate biopharma research.
مستشفى الملك فيصل التخصصي ومركز الأبحاث
نظير مبادرته الرائدة في مجال غسيل الكلى المنزلي "التخصصي" يفوز بجائزة التأثير التقني من VBHC للعام 2024 الرياض, May 16, 2024 (GLOBE NEWSWIRE) -- فاز مستشفى الملك فيصل التخصصي ومركز الأبحاث بجائزة التأثير التقني للعام 2024، المقدمة من مركز الرعاية الصحية القائمة على القيمة الأوربي (Value-Based Health...
KFSH&RC - Riyadh
King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC King Faisal Specialist Hospital & Research Centre Wins 2024 Tech Impact Award from VBHC
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations King Faisal Specialist Hospital and Research Centre Welcomes New Deputy CEO Amid Strategic Transformations
KFSH&RC CEO at GCC Harvard 1
KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending Value KFSH&RC Strives to Pioneer in Maximizing Healthcare Spending ValueDr. Al Fayyadh at Harvard: We Leverage Technology to Tackle Global Health Challenges